Watson Pharmaceuticals Recent News
Piper Jaffray Raises PT On Watson Pharmaceuticals To $76
Credit Suisse's Estimates and Price Target Changes
Citi Reiterates Buy on Watson Pharmaceuticals, Raises PT to $72
Piper Jaffray Reiterates Overweight and PT of $72 on Watson Pharmaceuticals
UPDATE: Piper Jaffray Color On WPI Target Increase
Piper Jaffray Raises PT On Watson Pharmaceuticals To $72
Citi Reiterates Buy on Watson Pharmaceuticals (WPI)
Citi Maintains Buy Rating On WPI
Morgan Stanley Reports Mylan Seeking FDA Approval Of Generic Lipitor In June 2011 For Watson Pharmaceuticals
Citigroup On Watson Pharmaceuticals Following Healthcare Conference
J.P. Morgan Refining Watson Pharmaceuticals Model Following 10-K
Morgan Stanley Raises PT on Watson Pharmaceuticals to $63 (WPI)
Morgan Stanley Initiates Watson Pharmaceuticals Coverage With An OW Rating And $61 PT
Watson Pharmaceuticals, Inc. To Benefit From Johnson & Johnson Deal
Generic Version Of Concerta To Have Modest Impact On Johnson & Johnson, Piper Jaffray Reports
Watson Pharmaceuticals Upgraded To Buy
Watson Pharmaceuticals (WPI) Reports $56.9 Million Profit